Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells.

    Research output: Contribution to journalArticleScientificpeer-review

    26 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)46-50
    JournalBiochemical and Biophysical Research Communications
    Volume481
    Issue number1-2
    DOIs
    Publication statusPublished - 2016
    Publication typeA1 Journal article-refereed

    Publication forum classification

    • Publication forum level 1

    Cite this